Breaking News
Investing Pro 0
Cyber Monday SALE: Up to 54% OFF InvestingPro+ CLAIM OFFER

4 Stocks To Watch: COLL, MRTX, NKTR, OSTK

By Harry BoxerStock MarketsNov 14, 2017 12:24AM ET
www.investing.com/analysis/coll-mrtx-nktr-ostk-200264766
4 Stocks To Watch: COLL, MRTX, NKTR, OSTK
By Harry Boxer   |  Nov 14, 2017 12:24AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
HMNY
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NKTR
-1.22%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
OSTK
+3.13%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CTLP
+0.59%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MX
+0.51%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MRTX
+2.89%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) swing trade worked out really well. I gave it to you in the 10 1/2 range, immediately ripped and didn’t stop until Monday, popping 52 cents, or 3.69%, to 14.61, on 1.5 million shares traded. it reached my first target at 13 1/2. My next target is 17. At this point, I’m not sure it will get to 17, so let’s make it 16 1/2 first. It might pull back and consolidate, and if it does, it’s going to be a set up.

Mirati Therapeutics, Inc. (NASDAQ:MRTX) is one of our swing trades that is acting well. It held support, and moved up 45 cents, or 3%, to 15.50, on 390,538 shares traded on Monday. It’s now testing resistance at 16 1/2, my target. At this point, it looks like it’s going to 20.

What a swing Nektar Therapeutics (NASDAQ:NKTR) has been. In about a week, it went from 23.00 to 41.00. Up 18 points. On Monday, it closed up 4.60, or 14%, to 37.10, on 17.4 million shares traded. The bottom line is that it hit resistance right at the zone at the top of the channel, and it’s way overbought, and it did come down off the high. Let’s see if it backs and fills, and consolidates before it goes higher. It has 12.7 days to cover .

Overstock.com, Inc. (NASDAQ:OSTK) just keeps going. On Monday, it ran 3.15, or 6%, to 56.30, on 3.7 million shares traded and reached the top of the channel my target in the mid 50’s. That doesn’t mean it can’t accelerate and get to 65, or even 75. Those are the targets going forward.

On the long side, stocks included ADAMS, BioLife Solutions, Inc. (NASDAQ:BLFS), Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), Collegium Pharmaceutical, Inc. (NASDAQ:COLL), Forterra, Inc. (NASDAQ:FRTA), Helios and Matheson Analytics Inc. (NASDAQ:HMNY), Mirati Therapeutics, Inc. (NASDAQ:MRTX), MagnaChip Semiconductor Corporation (NYSE:MX), Nektar Therapeutics (NASDAQ:NKTR), Ophthotech Corporation (NASDAQ:OPHT), Overstock.com, Inc. (NASDAQ:OSTK), Roku, Inc. (NASDAQ:ROKU), Trupanion, Inc. (NASDAQ:TRUP), TransEnterix, Inc. (NYSE:TRXC), USA Technologies, Inc. (NASDAQ:USAT), 58.com Inc. (NYSE:WUBA).

4 Stocks To Watch: COLL, MRTX, NKTR, OSTK
 

Related Articles

Michael Kramer
Big Week Ahead for Markets   By Michael Kramer - Nov 28, 2022 3

It will be a big week, with a ton of economic data ramping up on Tuesday and then going into overdrive on Wednesday. Jay Powell will highlight the week on Nov. 30 at 1:30 PM ET. I...

Michele Schneider
What To Expect From Retail By Michele Schneider - Nov 28, 2022

Investors and retailers are also closely monitoring consumption over the holiday weekend. The National Retail Federation estimates that 166.3 million Americans will shop through...

4 Stocks To Watch: COLL, MRTX, NKTR, OSTK

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email